The PSPH expression level was significantly associated with clinicopathological features, including lymph node and distal metastasis (P = 0.010) and advanced tumor node metastasis (TNM) stages (P = 0.0003), but not with age, gender, pathological type, differentiation, or tumor size. Here, PSPH is linked to neoplasm.